Strata Critical Medical, Inc.
SRTA
$5.43
-$0.06-1.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 74.15% | 34.28% | 5.60% | -20.58% | -43.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.15% | 34.28% | 5.60% | -20.58% | -43.29% |
| Cost of Revenue | 72.21% | 33.09% | 6.39% | -18.79% | -43.78% |
| Gross Profit | 81.83% | 38.99% | 2.64% | -27.11% | -41.23% |
| SG&A Expenses | 25.80% | 3.43% | -2.94% | -11.67% | -46.75% |
| Depreciation & Amortization | 145.50% | 139.43% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.25% | 24.91% | 3.28% | -17.03% | -45.13% |
| Operating Income | 47.68% | 40.26% | 12.89% | -12.57% | 56.21% |
| Income Before Tax | -19.30% | -24.16% | 49.40% | 51.98% | 73.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.56% | -24.16% | 48.19% | 50.82% | 72.99% |
| Earnings from Discontinued Operations | 11,141.33% | 4,588.02% | 1,601.47% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 276.90% | 251.42% | 178.49% | 61.43% | 46.99% |
| EBIT | 47.68% | 40.26% | 12.89% | -12.57% | 56.21% |
| EBITDA | 94.84% | 63.41% | 10.03% | -23.78% | 64.19% |
| EPS Basic | 267.77% | 242.43% | 170.67% | 63.33% | 49.45% |
| Normalized Basic EPS | 80.19% | 73.25% | -0.09% | -136.48% | 55.33% |
| EPS Diluted | 266.75% | 239.85% | 169.58% | 62.67% | 49.93% |
| Normalized Diluted EPS | 80.19% | 73.25% | -0.09% | -135.47% | 55.39% |
| Average Basic Shares Outstanding | 6.35% | 6.01% | 5.30% | 5.20% | 5.14% |
| Average Diluted Shares Outstanding | 7.90% | 6.01% | 5.30% | 2.86% | 2.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |